CytoSorbents Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
Cytosorbents (CTSO) Tops Q1 EPS by 5c
May 8, 2017 4:37 PM EDTCytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.2 million.
Total Q1 2017 revenues increased 72% to $3.1 million, which includes both product sales and grant income, from $1.8... More